Borrelia p100

Borrelia Burgdorferi p100 Recombinant
Cat. No.
BT29433
Source
Sf9 insect cells.
Synonyms
Appearance
Sterile Filtered clear solution.
Purity
Greater than 80.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Borrelia Burgdorferi p100 (p100/p83) produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 77,813 Dalton.
Borrelia p100 is expressed with a -6x His tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Borrelia is a genus of bacteria classified under the spirochete phylum. These bacteria are responsible for causing borreliosis, a vector-borne zoonotic disease primarily transmitted through ticks and, in some cases, lice, depending on the specific species. Among the 36 identified Borrelia species, 12 are known to cause Lyme disease or borreliosis and are spread by ticks. The primary species implicated in Lyme disease are Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. Members of the Borrelia genus possess a linear chromosome approximately 900 kbp in length, along with an abundance of both linear and circular plasmids ranging in size from 5 to 220 kbp. These plasmids are considered atypical compared to those found in most bacteria due to their high content of paralogous sequences, a significant number of pseudogenes, and, in certain instances, essential genes. Notably, several plasmids exhibit characteristics suggesting they might be prophages.
Description
Recombinant Borrelia Burgdorferi p100 (p100/p83), produced in SF9 insect cells, is a glycosylated polypeptide chain with a calculated molecular mass of 77,813 Daltons. It is expressed with a 6x Histidine tag (6x His-tag) at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
Borrelia p100 is supplied at a concentration of 0.77 mg/ml in a buffer solution containing 20mM HEPES (pH 8.0), 200mM NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To maintain product integrity, avoid repeated cycles of freezing and thawing.
Purity
The purity of the product is determined to be greater than 80.0% based on SDS-PAGE analysis.
Applications
This product is suitable for use in Western blot analysis with plasma samples from Lyme disease-positive individuals.
Source
Sf9 insect cells.

Product Science Overview

Introduction

Borrelia burgdorferi is a spirochete bacterium responsible for Lyme disease, a tick-borne illness that affects humans and animals. The bacterium is transmitted through the bite of infected Ixodes ticks. Among the various proteins expressed by Borrelia burgdorferi, the p100 protein, also known as p83, is of particular interest due to its role in the immune response and its potential use in diagnostic assays.

Borrelia Burgdorferi p100 Protein

The p100 protein is a high-molecular-weight protein that is expressed on the surface of Borrelia burgdorferi. It is one of the immunodominant antigens, meaning it elicits a strong immune response in infected individuals. The protein has a calculated molecular mass of approximately 77,813 Daltons and is glycosylated, which means it has sugar molecules attached to it .

Recombinant p100 Protein

Recombinant p100 protein is produced using genetic engineering techniques. The gene encoding the p100 protein is cloned into an expression vector, which is then introduced into a host cell, such as the SF9 insect cell line. The host cells produce the p100 protein, which is then purified using chromatographic techniques. The recombinant p100 protein is often tagged with a His-tag at the N-terminus to facilitate purification .

Applications in Diagnostics

The p100 protein is used in serological assays to diagnose Lyme disease. Serological assays detect antibodies produced by the immune system in response to infection. The p100 protein is included in enzyme-linked immunosorbent assays (ELISAs) and immunoblots as an antigen to capture antibodies from patient samples. The presence of antibodies against p100 in a patient’s serum indicates exposure to Borrelia burgdorferi .

Advantages of Recombinant p100 Protein
  1. High Sensitivity and Specificity: Recombinant p100 protein provides high sensitivity and specificity in serological assays, making it a reliable marker for Lyme disease diagnosis.
  2. Consistency: Recombinant production ensures a consistent supply of high-quality protein, reducing variability in diagnostic tests.
  3. Ease of Purification: The His-tag facilitates easy purification of the recombinant protein, ensuring high purity and yield .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.